8-K - TransCode Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Securities Issuance

Disclosure

Mandatory

Variant

8-K

Items Reported

3.02

Unregistered Sales of Equity Securities. The information contained in Item 8.01 of this Current Report is incorporated by reference into this Item 3.02. The sec

Securities Issuance

3.03

. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. Certificate of Designation On March 2, 2026, the Company filed a Certifica

Securities Modification

7.01

of this Current Report on Form 8-K, shall not be deemed to be incorporated by reference in the filings of the Company under the Securities Act. Item 8.01 Other

Regulation Fd

8.01

below. The Certificate of Designation provides for the designation of shares of the Series C Preferred Stock. Holders of Series C Preferred Stock are not entitl

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits . Exhibit Number Description 3.1 Certificate of Designation of Series C Non-Voting Convertible Preferred Stock o

Exhibits Only

Exhibits (3)

3.1

EXHIBIT 3.1

8-K

FORM 8-K

99.1

EXHIBIT 99.1